Research Paper Volume 16, Issue 6 pp 5545—5566
A pyrimidine metabolism-related signature for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma by integrating analyses
Figure 10. Drug sensitivity analysis. (A) Afatinib. (B) Axitinib. (C) Cediranib. (D) Dasatinib. (E) Gemcitabine. (F) GNE-317. (G) Gefitinib. (H) Ipatasertib. (I) Selumetinib. (J) Sorafenib. (K) Osimertinib. (L) Oxaliplatin. (M) The correlation between the drug sensitivity and expression levels of the four model genes.